NCBiotech News

Gerry Hancock, NCBiotech's original board chair, served two terms in the State Senate and co-chaired the General Assembly’s Legislative Commission on Biotechnology. He was recently honored with a Peabody Award.

Durham-based BioSkryb Genomics has signed with Cooper Genomics to license BioSkryb’s proprietary genomic amplification technology for genetic testing of embryos prior to implantation in women seeking to become pregnant through in vitro fertilization.

Michele Chang, the U.S. EDA’s deputy assistant secretary for policy, liked what she saw as she led a contingent to North Carolina’s Research Triangle area to review how partners were doing on their $25 million grant plans.

The EPA has approved RTP-based AgBiome’s new combination fungicide to treat foliar diseases, Esendo.

Seqirus, a global vaccine maker with a newly expanded manufacturing plant in Holly Springs, has signed a $30.1 million federal contract to produce a potential vaccine against avian flu.

Durham-based biotechnology startup Tavros Therapeutics will partner with Bayer AG subsidiary Vividion Therapeutics to find new targets and treatments for cancer.

PPD, the Wilmington-based clinical research business of Thermo Fisher Scientific, has been awarded a 10-year NCI contract to support cancer clinical trials.

Durham-based Praetego, a pharmaceutical company focused on treating neurodegenerative diseases related to aging, has received a $2.5 millionNIH grant to advance its lead drug candidate against Alzheimer’s disease.

Curie Co, an early stage enzymes company based in New York City, has relocated to Research Triangle Park and hired an industry veteran with North Carolina ties as its chief technology officer.

The Mushroom Meat Company, a Chapel Hill food tech startup, is winning kudos for its plant-based meat substitutes in a fast-growing market segment.

Central Carolina Community College recently welcomed its first Biotechnology Pathway Navigator to give BioWork and biotechnology students a leg up when pursuing a career in biomanufacturing and the life sciences.

Georgia placental biologics company MIMEDX will have a laboratory in the RegeneratOR Innovation Accelerator in Winston-Salem’s Innovation Quarter.

Cary-based Chiesi USA continues to expand its diversity, equity and inclusion efforts through partnerships and research funding that directly support North Carolina students and researchers.

Johnston County commissioners have approved performance-based economic development incentives in support of anticipated new investments during the coming 12 years by global biomanufacturing giant Novo Nordisk.

BD, a global medical device manufacturer with four North Carolina sites, today announced plans for a potential $30 million expansion of its Four Oaks campus that will create 22 new jobs.